Easyjet Plc (EJT1)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 8.078 |
|---|---|
| 52-week range | 3.888 – 8.150 |
| Return, 1 month / 3 months | +3.8% / +18.2% |
| Return, 1 year / 3 years | +44.2% / +107.7% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -32.6% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EasyJet is a low-cost airline based in Britain that flies short-haul routes between cities across Europe. It carries leisure and business passengers on a point-to-point network, using a single family of Airbus aircraft. Customers book seats directly through the airline's website and mobile app, and pay extra for things such as checked bags, seat selection and onboard food. The company focuses on frequent, no-frills service between primary and secondary airports, keeping fares low by simplifying its operations.
On this site Easyjet Plc appears as a stock on the XETRA Stock Exchange (Germany), code EJT1, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Easyjet Plc (EJT1) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 8.078 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 116 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 44.2% and over the last three months it rose 18.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 33.2% | ||
| From 52-week high | -0.6% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.2% | ||
| 6-month return | 88.3% | ||
| 12-month return, skipping the last month | 38.9% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.6% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +3.8% |
| 3 months | +18.2% |
| 6 months | +88.3% |
| 1 year | +44.2% |
| 3 years | +107.7% |
| 5 years | +20.0% |
Signals
| 50-day / 200-day average | 7.884 / 6.066 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.059 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Feb 2026 | GBP 0.1565 |
| 20 Feb 2025 | GBP 0.1434 |
| 22 Feb 2024 | GBP 0.0533 |
| 27 Feb 2020 | GBP 0.5204 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.